These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32384878)

  • 21. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
    Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH;
    Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.
    Minutolo R; Sasso FC; Chiodini P; Cianciaruso B; Carbonara O; Zamboli P; Tirino G; Pota A; Torella R; Conte G; De Nicola L
    J Hypertens; 2006 Aug; 24(8):1655-61. PubMed ID: 16877970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.
    Ghamri RA; Alzahrani NS; Alharthi AM; Gadah HJ; Badoghaish BG; Alzahrani AA
    BMC Cardiovasc Disord; 2019 Nov; 19(1):268. PubMed ID: 31775642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
    Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y
    J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service.
    Ahmed AA; Alsharief E; Alsharief A
    Diabetes Metab Syndr; 2013; 7(3):133-7. PubMed ID: 23953177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].
    Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR
    Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
    Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
    Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
    Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
    Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
    Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
    Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in the achievement of HbA
    Bakke Å; Dalen I; Thue G; Cooper J; Skeie S; Berg TJ; Jenum AK; Claudi T; Fjeld Løvaas K; Sandberg S
    Diabet Med; 2020 Sep; 37(9):1471-1481. PubMed ID: 31651045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
    Du T; Yuan G; Zhou X; Sun X
    Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Do we reach target lipid levels in diabetic and non-diabetic patients with previous myocardial infarction?].
    Aleksić E; Stamenković R; Lapcević M; Deljanin-Ilić M; Djordjević D; Tasić I
    Srp Arh Celok Lek; 2011; 139(1-2):30-6. PubMed ID: 21568080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region.
    Cambra K; Galbete A; Forga L; Lecea O; Ariz MJ; Moreno-Iribas C; Aizpuru F; Ibañez B
    BMC Fam Pract; 2016 Oct; 17(1):144. PubMed ID: 27729015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary care obesity management in Hungary: evaluation of the knowledge, practice and attitudes of family physicians.
    Rurik I; Torzsa P; Ilyés I; Szigethy E; Halmy E; Iski G; Kolozsvári LR; Mester L; Móczár C; Rinfel J; Nagy L; Kalabay L
    BMC Fam Pract; 2013 Oct; 14():156. PubMed ID: 24138355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.